Clinical Trials
3 trialsNCT05941325 2026-06-05
A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
Shanghai 6th People's Hospital
Phase 2 Suspended
NCT06202599 2024-01-17
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Peking University People's Hospital
Completed
NCT05142631 2022-03-02
Fruquintinib in the Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown